Abstract:We investigated the location and function of subunit‐specific AMPA receptors in the mouse locus coeruleus (LC). We determined that the GluA1 and GluA4 subunits are expressed in noradrenergic neurons of the LC, using immunohistochemistry and confocal microscopy. No specific signal was detectable for the GluA2 and GluA3 subunits. Whole patch clamp recordings in acute brain slices revealed that the pharmacological activation of GluA1‐containing AMPA receptors increased LC spontaneous firing rate, whilst their inhibition had the opposite effect. In contrast, the pharmacological activation of GluA4‐containing AMPA receptors had no significant effect on LC spontaneous firing rate. This suggests that different AMPA receptor subtypes have contrasting contributions to LC neuronal electrical excitability. The locus coeruleus (LC) provides the principal supply of noradrenaline (NA) to the brain, thereby modulating an array of brain functions. The release of NA, and therefore its impact on the brain, is governed by LC neuronal excitability. Glutamatergic axons, from various brain regions, topographically innervate different LC sub‐domains and directly alter LC excitability. However, it is currently unclear whether glutamate receptor sub‐classes, such as α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptors, are divergently expressed throughout the LC. Immunohistochemistry and confocal microscopy were used to identify and localise individual GluA subunits in the mouse LC. Whole‐cell patch clamp electrophysiology and subunit‐preferring ligands were used to assess their impact on LC spontaneous firing rate (FR). GluA1 immunoreactive clusters were associated with puncta immunoreactive for VGLUT2 on somata, and VGLUT1 on distal dendrites. GluA4 was associated with these synaptic markers only in the distal dendrites. No specific signal was detected for the GluA2‐3 subunits. The GluA1/2 receptor agonist (S)‐CPW 399 increased LC FR, whilst the GluA1/3 receptor antagonist philanthotoxin‐74 decreased it. 4‐[2‐(phenylsulfonylamino)ethylthio]‐2,6‐difluoro‐phenoxyacetamide (PEPA), a positive allosteric modulator of GluA3/4 receptors, had no significant effect on spontaneous FR. The data suggest distinct AMPA receptor subunits are targeted to different LC afferent inputs and have contrasting effects on spontaneous neuronal excitability. This precise expression profile could be a mechanism for LC neurons to integrate diverse information contained in various glutamate afferents.

AMPA receptors are present on mouse lymphocytes and AMPA receptor antagonist, GYKI-52466, inhibits lymphocyte proliferation. (50.31)

Integrins Regulate Nmda Receptor-Mediated Synaptic Currents

Long-term Potentiation Alters the Modulator Pharmacology of AMPA-type Glutamate Receptors.

AMPA Receptor-Mediated Regulation of a Gi-protein in Cortical Neurons

Activation of GABA(A) receptors inhibits T cell proliferation

Analysis of the Cellular Mechanism Underlying Inhibition of EAE after Treatment with Anti-Nkg2a F(ab′)2

Physiological and Molecular Properties of AMPA/Kainate Receptors Expressed by Striatal Medium Spiny Neurons

Glutamate stimulates oligodendrocyte progenitor migration mediated via an alphav integrin/myelin proteolipid protein complex

The Inhibitory Effect of Α/β-Hydrolase Domain-Containing 6 (ABHD6) on the Surface Targeting of GluA2- and GluA3-Containing AMPA Receptors

Recent Insights into the Functional Role of AMPA Receptors in the Oligodendrocyte Lineage Cells In Vivo

SynDIG1 Promotes Excitatory Synaptogenesis Independent of AMPA Receptor Trafficking and Biophysical Regulation

Hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo adaptative changes following enriched environment training

Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity

The diversity of AMPA receptor inhibition mechanisms among amidine-containing compounds

AMPA-ergic regulation of amyloid-β levels in an Alzheimer's disease mouse model

Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia

AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines

Suppression of Γ-Aminobutyric Acid Transporter Current by Activation of Ionotropic Glutamate Receptors on Retinal Horizontal Cells

Characterization of AMPA Receptors on Isolated Amacrine-Like Cells in Carp Retina.

Subunit‐specific expression and function of AMPA receptors in the mouse locus coeruleus

Rapid Spine Delivery and Redistribution of AMPA Receptors after Synaptic NMDA Receptor Activation.